Information about HemoCue intellectual property rights – trademarks and patents – and legal information regarding the use of hemocue.com
Patents
HemoCue products may be covered by one or more of the following patents, patent applications and designs.
HEMOGLOBIN
HemoCue® Hb 801 System
SE 542103; JP 6857287; AU 2018363712; CN 111447998; RCD 004500106-0001; US D870,315S; IN 305250; UKD 90045001060001
HemoCue® Hb 301 System
RCD 000503230
WHITE BLOOD CELL (WBC) COUNT
HemoCue® WBC System
US 7,633,615; EP 2041581; SE 601576; AU 2007275925; ZL 200780026238.X; NO 340137; SE 700086; EP 1947441
HemoCue® WBC DIFF System
US 7,633,615; EP 2041581; SE 601576; AU 2007275925; ZL 200780026238.X; NO 340137; US 8,224,058; SE 601575; EP 2041549; SE 700958; AU 2007275927; ZL 200780026960.3; NO 343728; US 8,009,894; SE 800117; ZL 200980102032.X; IN 290425; JP 5129347
Trademarks
HemoCue, the drop symbol with or without HemoCue, and the microcuvette symbol with or without HemoCue are trademarks of HemoCue AB.
All or some of the trademarks are registered in Argentina, Australia, Brazil, Canada, China, Columbia, Egypt, the EU, the United Kingdom, Hong Kong, Iceland, India, Indonesia, Japan, Kenya, Malaysia, Mexico, New Zealand, Nigeria, Norway, Peru, Russia, Singapore, Israel, South Africa, South Korea, Switzerland, Taiwan, Tanzania, Turkey, and the USA.
HemoCue®
